Benzo (G) quinoline derivatives for treating glaucoma and myopia

Details for Australian Patent Application No. 2002328856 (hide)

Owner Novartis AG

Inventors Markstein, Rudolf; Gull, Peter; Pombo Villar, Esteban

Agent Davies Collison Cave

Pub. Number AU-B-2002328856

PCT Number PCT/EP02/07594

PCT Pub. Number WO2003/006458

Priority 01116553.7 09.07.01 EP

Filing date 8 July 2002

Wipo publication date 29 January 2003

Acceptance publication date 4 August 2005

International Classifications

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 031/505 - Pyrimidines

A61P 027/02 Drugs for disorders of the senses

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 01116553.7 09.07.01 EP

22 May 2003 Application Open to Public Inspection

  Published as AU-B-2002328856

4 August 2005 Application Accepted

  Published as AU-B-2002328856

1 December 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002328857-DEPOT POLYMERIZATION STARTER BEADS

2002328855-Prostaglandin Analogues As EP4 Receptor Agonists